Lung cancer & Mesothelioma. Immunotherapy believer.
Joined June 2019
- Tweets3.7K
- Following2.5K
- Followers7K
- Likes8K
Pinned Tweet
~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In @NEJM today & presented at #ASCO25 5 yr survival for pts w lung cancer that can be removed by surgery is better with just 3 doses of immunotherapy before the operation! nejm.org/doi/full/10.1056/NE… #LCSM 1/
Patrick Forde retweeted
Sat
Morning
Live
From NY!
Please make sure u sign up to join us for our 21st @gotoPER New York Lung event on 11/14!
☑️Amazing faculty from A to Z.. sorry A to Y (Aggarwal to Yu)
☑️Covering all relevant/new/emerging topics
☑️Challenging cases
☑️Tumor boards
☑️and now 1st time ever fellows’ competition/poster walk
..
And did i mention closing cocktail reception?
So- what are u waiting for??
registration.gotoper.com/nyl…
@benlevylungdoc @lungoncdoc @BrendonStilesMD @HosseinBorghaei @FordePatrick @DDoroshow @DrHaigentz @bherzbergmd @NagashreeSeeth1 @DrAshish_Saxena @JSabari
Patrick Forde retweeted
That’s a wrap for #AILCC26 🇮🇪
Thanks to our speakers, chairs & attendees for a dynamic meeting, full of energy, ideas & exchange. A special thank you to our sponsors & international speakers from 🇪🇸🇨🇭🇮🇹 🇺🇸, what a community #AnneBedford #ElaineQuinn #GeraldineArnott & @roche_san
Patrick Forde retweeted
As another All-Ireland Lung Cancer Conference comes to an end, a huge shout out to my 2 conference co-chairs @DrJNaidoo and @FordePatrick who are just the best to work with.
Delighted that the meeting has been a great success and huge 🙏 to all the Speakers, Chairs and supporting staff.
Thanks to all the Healtcare professionals and researchers from across Ireland who gave up their weekend to be there and make the meeting a success.
@cancertrials_ie
@CancerInstIRE
@CancerCentreIre
@TrinityMed1
Patrick Forde retweeted
Superb talk at #AILCC26 from @StephenVLiu on the latest in SCLC:
- BiTEs: Tarla now a SOC in 2L (awaiting Irish approval) and new data due to come out at #ESMO26
- ADCs: B7H3 ADCs showing survival benefit in ph III trials (e.g: Tam-Peli), more to come
#LCSM
Patrick Forde retweeted
Great to share some thoughts on “Mentorship 101” at the #AILCC26 🇮🇪
One concept I wanted to highlight: hedonic adaptation or “becoming accustomed to success”
Yesterday’s dream becomes today’s normality and tomorrow’s expectations.
In medicine, we constantly chase the next publication, grant, promotion or achievement. But do we ever stop to appreciate how far we’ve come?
We guide a d help our mentees on how to be successful. How about guiding them on how to feel successful? @DrJNaidoo @FordePatrick @gerryhanna
#Mentorship #MedicalEducation #Leadership
Patrick Forde retweeted
Dr. @peters_solange opens day 2 of #AILCC26 with a look at the coming decade for lung cancer. Highlights screening, liquid biopsy, early stage, next gen immunotherapy and access. What is the value of innovation if patients cannot access it (or worse, inequity in access).
Patrick Forde retweeted
Day 2 of #AILCC26 starts with keynote speaker @peters_solange taking us through the next 10yrs of NSCLC, key themes:
- screening: broadening the population?
- liquid biopsy: optimising PPV
- AI: 3 doors of innovation, radiology & pathology first
- next gen IO: TCEs & more
#LCSM – at Kildare, Ireland
Patrick Forde retweeted
Visionary talk today on day 2 at #AILCC26 from @peters_solange on the next decade of lung cancer care @FordePatrick @gerryhanna @peters_solange @PatelOncology @Alfdoc2 @MARIANOPROVENCI @APassaroMD @fifimcdrmh @gwalls89 @DrJNaidoo
Patrick Forde retweeted
#AILCC26 Immunotherapy session featuring @FordePatrick & @CancerInstIRE #RebeccaWeedle who asks provocative questions on:
- wedge v lobectomy post neoadj
- surgical experience that cannot be captured through traditional tox methods
- surgical guidelines: stage III N2 only?
#LCsM
Patrick Forde retweeted
Dr. @FordePatrick at #AILCC26 discusses patient selection for neoadjuvant chemoimmunotherapy. One challenge with gene signatures and tumor informed ctDNA is limited tissue from initial biopsy which is already needed for EGFR testing etc. tumor agnostic ctDNA an option?
Patrick Forde retweeted
Great to get the All-Ireland Lung Cancer Conference 2026 underway today.
Leading out conference Chair @DrJNaidoo gets #AILCC2026 proceedings underway.
At really superb line up ahead including
@MARIANOPROVENCI
@peters_solange
@StephenVLiu
@PatelOncology
@fifimcdrmh
@Alfdoc2
Dr Antonio Passaro
Professor Tina Cascone
Patrick Forde retweeted
Thrilled to join Dr. @DrJNaidoo for the 12th All Ireland Lung Cancer Conference 🇮🇪! Excited to learn from experts in Ireland and around the world @FordePatrick @gerryhanna @peters_solange @PatelOncology @Alfdoc2 @MARIANOPROVENCI @APassaroMD @fifimcdrmh @gwalls89
Dr. @MARIANOPROVENCI @gecp_org delivers the opening keynote address of #ailcc26 - neoadjuvant immunotherapy a paradigm shift!
Our chair Dr. @DrJNaidoo opens the 12th All Ireland Lung cancer meeting, great discussions in prospect! #lcsm
Patrick Forde retweeted
MRD and Adjuvant Disease: Resectable NSCLC Beyond Neoadjuvant Therapy—
@christine_lovly, @max_diehn, and Patrick Forde will address this topic in a plenary at the AACR Conference on Lung Cancer (January 14-17; San Diego).
brnw.ch/21x6pqX
#AACRlung27 @FordePatrick
Patrick Forde retweeted
All star panel at #DCLung26 discussing SCLC, mesothelioma, and thymic cancer challenging cases: Drs. @drshieldsmd , @Annechiangmd , @FordePatrick , @BrendonStilesMD
Patrick Forde retweeted
T-2 weeks until the All Ireland Lung Cancer Conference!
Calling all young investigators, submit your abstract by Mon Oct 5th at 9am for a chance to present your work to an esteemed panel led by @Alfdoc2, & the chance to win cash prizes for your research/education
Join us! #LCSM
